Study of AR-13324 in Patients With Elevated Intraocular Pressure
Public ClinicalTrials.gov record NCT01528787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of AR-13324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In this double-masked, vehicle-controlled, dose-response study, subjects will be randomized to receive AR-13324 Ophthalmic Solution 0.01%, 0.02%, and 0.04% or its vehicle (one eye), once daily (QD)in the morning (AM) for 7 days. The first dose and last dose will be administered in the clinic. Ocular safety and ocular hypotensive efficacy will be evaluated in the clinic throughout the study.
Study identification
- NCT ID
- NCT01528787
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 85 participants
Conditions and interventions
Conditions
Interventions
- AR-13324 Ophthalmic Solution 0.01% Drug
- AR-13324 Ophthalmic Solution 0.02% Drug
- AR-13324 Ophthalmic Solution 0.04% Drug
- AR-13324 Ophthalmic Solution Vehicle Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2012 (Type not available)
- Primary completion
- Jul 2012 (Actual)
- Completion
- Jul 2012 (Actual)
- Last update posted
- Apr 18, 2018
2012
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aesthetic Eye Care Institute | Newport Beach | California | 92657 | — |
| Robert Noecker, M.D., M.B.A. | Fairfield | Connecticut | 06824 | — |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | — |
| Heart of America Eye Care, P.A. | Shawnee Mission | Kansas | 66204 | — |
| Comprehensive Eye Care | St Louis | Missouri | 63090 | — |
| Rochester Ophthalmology Group | Rochester | New York | 14618 | — |
| The Eye Institute | Tulsa | Oklahoma | 74104 | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Univ Eye Surgeons, Maryville Ctr. | Maryville | Tennessee | 37803 | — |
| Texan Eye | Austin | Texas | 78731 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01528787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01528787 live on ClinicalTrials.gov.